fbpx Diary from FENS 2014 - Day Two | Science in the net

Diary from FENS 2014 - Day Two

Read time: 2 mins

Sunday. Second day of the FENS. When the poster session started. It will gather almost 4,000 posters until the end of the congress. And here is my personal top three of this day.

3 – Alessandro Usiello, University of Naples, Italy

Alessandro Usiello’s lab performed extensive studies on the role of D-aspartate in hippocampus, showing how this amino acid can increase NMDAR activity. Increasing D-aspartate levels also allowed reverting the effects of the psychoactive drugs PCP (Angel Dust), which usually reduces NMDAR activity. Moreover, D-aspartate administrations in schizophrenic patients allowed improving the symptoms of the disease. These results gave an important new path in the treatment of schizophrenic disease and shed new light in the general knowledge on D-aspartate functions.

2 – Anna Nobre, University of Oxford, United Kingdom

Anna Nobre gave an exhaustive lesson on the principles and the history of attention studies, an aspect of behavior that is key to any task we commonly perform. Her experiments required the collaboration of volunteers that had to perform specific tasks while being recorded through an external electrode, in order to see their brain activity in different regions. Nobre’s contribution to understanding this mechanisms focused mainly on decoding the biology and physiology of temporal expectation, demonstrating many of the mechanisms we are all able to use in order to improve our responses performances to many tasks.

1 – Alexander Bonnin, University of Southern California, USA

Alexander Bonnin is investigating the role of fetal programming and development diseases. His lab developed a system that can culture developing mouse embryos maintained inside the placenta: this system also allows controlling the molecules that are being injected in the placenta and reach the embryo. Using this set up, Bonnin’s team studied the integration of Citaloran, a common anti-depressive drug used for pregnancy depression. Such a model is used to study in more detail the pharmacodynamics between placenta and embryonic tissues, in order to improve pharmacology with new molecules designed so that they do not pass the placenta and therefore do not affect the development of the embryo.

Articoli correlati

Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


prossimo articolo

Discovered a New Carbon-Carbon Chemical Bond

A group of researchers from Hokkaido University has provided the first experimental evidence of the existence of a new type of chemical bond: the single-electron covalent bond, theorized by Linus Pauling in 1931 but never verified until now. Using derivatives of hexaarylethane (HPE), the scientists were able to stabilize this unusual bond between two carbon atoms and study it with spectroscopic techniques and X-ray diffraction. This discovery opens new perspectives in understanding bond chemistry and could lead to the development of new materials with innovative applications.

In the cover image: study of the sigma bond with X-ray diffraction. Credits: Yusuke Ishigaki

After nearly a year of review, on September 25, a study was published in Nature that has sparked a lot of discussion, especially among chemists. A group of researchers from Hokkaido University synthesized a molecule that experimentally demonstrated the existence of a new type of chemical bond, something that does not happen very often.